Olivier Feron

Olivier Feron is a Professor of Translational Medicine at the University of Louvain (UCL, Brussels, Belgium) and holds the honorable title of Research Director Emeritus at the National Fund for Scientific Research (FNRS). He completed his PhD in Molecular Pharmacology, followed by postdoctoral training and an Instructor role in Medicine at Harvard Medical School and Brigham and Women's Hospital in Boston.

Research Interests: His work focuses on

• Targeting cancer metabolism through mitochondrial inhibitors
• Exploiting hypoxia for radiosensitization
• Nanomaterials in cancer immunotherapy
• Photodynamic therapy for leukemia-affected ovarian tissue
• Macrophage-endothelial cell interactions in metastasis
• pH-sensitive drug delivery systems

Editorial Roles: Specialty Chief Editor for Pharmacology of Anti-Cancer Drugs at Frontiers in Pharmacology, Guest Associate Editor for Molecular and Cellular Oncology at Frontiers in Oncology. Notably, he has contributed to 72 editorial works.

Scientific Awards:

• Honorary Research Director, FNRS

Collaborations: He is connected to prominent researchers across Belgium (Laure B Bindels, Sophie Laurent), the U.S. (Clary B Clish), and Saudi Arabia (Aminah Ahmad Alzailai).